Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma

Table 2 Clinical characteristics of tumors in the hepatocellular carcinoma group, n = 35

Number of the focal lesions	n (%)
Single	16 (45.7)
Multiple	19 (54.3)
Tumor size in cm
Small < 3	7 (20.0)
Medium 3-5	15 (42.9)
Large > 5	13 (37.1)
Location of the focal lesions
Rt. Lobe	19 (54.3)
Lt. Lobe	8 (22.9)
Both	7 (20.0)
Caudate lobe	1 (2.9)
BCLC stage
A	4 (11.4)
B	18 (51.4)
C	13 (37.1)
Vascular invasion
Negative	25 (71.4)
Positive	10 (28.6)
LN metastasis
Negative	28 (80.0)
Positive	7 (20.0)
Ascites
No	25 (73.5)
Mild	8 (23.5)
Moderate	1 (2.9)
Child Pugh classA	22 (62.9)
B	13 (37.1)
C	0 (0)
Distant metastasis
No	23 (65.7)
Yes	12 (34.3)

Rt.: Right; Lt.: Left; BCLC: Barcelona Clinic Liver Cancer; LN: Lymph node.